The Sept. 21 announcement states that Gadopiclenol Injection—a highly stable macrocyclic gadolinium-based contrast agent—is approved for use in adult and pediatric patients aged 2 years and older during MRI exams.
The acquisition represents a significant advance in interoperability and will combine networks that total over 80 billion images globally, including data from institutions such as Mayo Clinic, Cleveland Clinic and New York Presbyterian Hospital.
A new analysis published in Radiology details signs of persistent pulmonary dysfunction in children who have recovered from a COVID infection or who are experiencing symptoms of long-COVID.
By partnering with Hamamatsu, INFINITT can offer an enhanced integration with NanoZoomers, enabling laboratories and pathologists to seamlessly review slides in an end-to-end operational workflow.
This image gallery shows examples from various breast imaging modalities, including digital breast tomosynthesis, ultrasound and breast MRI, in addition to clinical presentations of breast cancer and other pathologies.
The new paper describes the imaging characteristics of metaplastic carcinoma of the breast and correlates the findings with clinical and histopathological characteristics/diagnoses.
After experts from one institution evaluated 500 portable chest x-rays completed during the summer of 2021, it was revealed that 46.2% of the images obtained were problematic, requiring the imaging to be repeated.
The treatment has the potential to “extend lifespans and improve quality of life” in patients with brain cancer, according to experts at UC San Diego Health.
